Response by Fotakis et al to Letter Regarding Article, "Anti-Inflammatory Effects of HDL (High-Density Lipoprotein) in Macrophages Predominate Over Proinflammatory Effects in Atherosclerotic Plaques"

Arterioscler Thromb Vasc Biol. 2020 Feb;40(2):e33-e34. doi: 10.1161/ATVBAHA.119.313737. Epub 2020 Jan 22.

Authors

Panagiotis Fotakis¹, Vishal Kothari², Karin E Bornfeldt², Alan R Tall¹

Affiliations

¹ From the Division of Molecular Medicine, Department of Medicine, Columbia University, New York (P.F., A.R.T.).
² Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, UW Medicine Diabetes Institute, University of Washington, Seattle (V.K., K.E.B.).

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Anti-Inflammatory Agents
Humans
Lipoproteins, HDL
Macrophages
Plaque, Atherosclerotic*

Substances

Anti-Inflammatory Agents
Lipoproteins, HDL

Grants and funding